Meeting
2021 ASCO Annual Meeting
Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) treated with systemic therapy: A systematic literature review (SLR) and meta-analysis.
Authors
Hussein Abdul-Hassan Tawbi
The University of Texas MD Anderson Cancer Center, Houston, TX
Hussein Abdul-Hassan Tawbi , Georgina V. Long , Nicolas Meyer , Boris Breznen , Charmy Vyas , Lisa Leung , Andriy Moshyk , Divya Pushkarna , Pratik K. Thakkar , Mir Sohail Fazeli , SRIVIDYA KOTAPATI , Dirk Schadendorf
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Advanced/Metastatic Disease
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9561)
DOI
10.1200/JCO.2021.39.15_suppl.9561
Abstract #
9561
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases: SWOG S2000.
First Author: Zeynep Eroglu
Poster
2023 ASCO Annual Meeting
Revisiting the optimal neoadjuvant immunotherapy regimen in resectable stage III melanoma based on the interferon gamma signature: A pooled analysis.
First Author: Minke W. Lucas
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases.
First Author: Jianbo Wang
Poster
2022 ASCO Annual Meeting
Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067.
First Author: F. Stephen Hodi